How We Can Help
Preclinical & Translational Strategy
- Translational Design: Preclinical experiments strategically aligned with current clinical landscape and unmet needs.
- Elucidation of Mechanism of Action: Validate underlying biology & the molecular drivers of the disease.
- Biomarker Discovery: Identify candidate biomarkers of response and design robust clinical assays for first in human validation.
- Advanced "Omics" Analysis: Expert interpretation of transcriptomics (bulk, single-cell/nuclei) from cell lines, tissues, and public datasets.
Clinical Development & Business Intelligence
- Clinical Data Interpretation: Analyzing and synthesizing results from early-phase clinical trials to inform next steps.
- Trial Design & Optimization: Design biomarker-driven protocols prioritizing clinical translatability and patient benefit.
- Competitive Intelligence: Comprehensive mapping of clinical landscapes and competitor pipelines to drive asset's differentiation.
Investment & Due Diligence
- Technical Due Diligence: Provide deep-dive scientific assessments of investment targets for VCs and strategic partners.
- Dataroom Management: Strategic setup and rigorous review of datarooms ensuring audit-ready status for fundraising or M&A.
Documents, Presentations & Regulatory
- Corporate & Scientific Communications: Review corporate decks and manuscripts; draft high-impact posters or presentations for major conferences (e.g., AACR, AHA, ASCO, ESC, SABCS).
- Regulatory Writing Support: Contribute technical expertise to IND, IB, and IP filings, as well as grant submissions.
- Strategic Literature & Conference Intelligence: Curated literature searches and tailored conference itineraries to maximize team impact and presence.
Additional Services
- Scientific Advisor
- Corporate Strategy & Execution, Business Development
- CRO Selection & Management
- Fractional Executive (VP, CSO)
- Effective Presentations (Scientific & General Audiences)
- Team Building and Cross-Functional Leadership
- Project Management (PMP)